146 related articles for article (PubMed ID: 33027604)
1. Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
Tan AL; Farrow M; Biglands J; Fernandes RJ; Abraldes JA; de Souza Castro FA; de Souza HL; Arriel RA; Meireles A; Marocolo M; González-Rayas JM; Rayas-Gómez AL; Mobayed-Vega FN; González-Yáñez JM; Hirai DM; Belbis MD; Holmes MJ; Calvo N; Ferguson SK; Fernandes T; Oliveira EM; Pun M; Bhandari SS
J Appl Physiol (1985); 2020 Oct; 129(4):868-871. PubMed ID: 33027604
[No Abstract] [Full Text] [Related]
2. Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
Ferrandi PJ; Alway SE; Mohamed JS
J Appl Physiol (1985); 2020 Oct; 129(4):872. PubMed ID: 33027605
[No Abstract] [Full Text] [Related]
3. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
Ferrandi PJ; Alway SE; Mohamed JS
J Appl Physiol (1985); 2020 Oct; 129(4):864-867. PubMed ID: 32673162
[No Abstract] [Full Text] [Related]
4. Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients.
Winkler T; Ben-David U
Int J Cancer; 2020 Dec; 147(11):3264-3266. PubMed ID: 32525565
[No Abstract] [Full Text] [Related]
5. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
6. ADAM17 inhibition may exert a protective effect on COVID-19.
Palau V; Riera M; Soler MJ
Nephrol Dial Transplant; 2020 Jun; 35(6):1071-1072. PubMed ID: 32291449
[No Abstract] [Full Text] [Related]
7. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
9. Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.
Alhenc-Gelas F; Drueke TB
Kidney Int; 2020 Jun; 97(6):1091-1093. PubMed ID: 32354636
[No Abstract] [Full Text] [Related]
10. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19.
Abd El-Aziz TM; Al-Sabi A; Stockand JD
Signal Transduct Target Ther; 2020 Nov; 5(1):258. PubMed ID: 33144565
[No Abstract] [Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
Monje MHG; Martínez-Fernández R
Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
[No Abstract] [Full Text] [Related]
12. Oral cancer and ACE2 receptor of SARS-CoV-2.
Martelli-Júnior H; Machado RA; Martelli DRB; Andrade MC; Coletta RD
Oral Oncol; 2020 Sep; 108():104920. PubMed ID: 32713810
[No Abstract] [Full Text] [Related]
13. Could DIZE be the answer to COVID-19?
Qaradakhi T; Gadanec L; Matsoukas J; Apostolopoulos V; Zulli A
Maturitas; 2020 Oct; 140():83-84. PubMed ID: 32636103
[No Abstract] [Full Text] [Related]
14. Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
Prentice RE; Tjandra D; Garg M; Lubel JS; Fourlanos S; Johnson D; Al-Ani A; Christensen B
Aliment Pharmacol Ther; 2020 Oct; 52(8):1422-1423. PubMed ID: 33105980
[No Abstract] [Full Text] [Related]
15. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
[TBL] [Abstract][Full Text] [Related]
16. Outsmarting SARS-CoV-2 by empowering a decoy ACE2.
Sokolowska M
Signal Transduct Target Ther; 2020 Nov; 5(1):260. PubMed ID: 33144557
[No Abstract] [Full Text] [Related]
17. Research progress in nervous system damage caused by SARS
Huang P; Tang L; Ren Y; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1247-1254. PubMed ID: 33268588
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: is the ACE2 just a foe?
Jakovac H
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1025-L1026. PubMed ID: 32233935
[No Abstract] [Full Text] [Related]
19. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.
Lim KH; Yang S; Kim SH; Joo JY
J Infect; 2020 Sep; 81(3):e33-e34. PubMed ID: 32619698
[No Abstract] [Full Text] [Related]
20. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.
Pascolo L; Zupin L; Melato M; Tricarico PM; Crovella S
J Dent Res; 2020 Sep; 99(10):1120-1121. PubMed ID: 32479133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
